330 likes | 669 Views
Flow Cytometric Opsonophagocytic Assays. Joseph E. Martinez CDC, Atlanta. S. pneumoniae. Multiplexed OPA work supported in part by a non-restricted CRADA with Flow Applications, Inc. and covered under US patent 6,815,172. Opsonophagocytic Assays (OPA ) Two approaches for OP measurement
E N D
Flow Cytometric Opsonophagocytic Assays Joseph E. Martinez CDC, Atlanta S.pneumoniae Multiplexed OPA work supported in part by a non-restricted CRADA with Flow Applications, Inc. and covered under US patent 6,815,172
Opsonophagocytic Assays (OPA) • Two approaches for OP measurement • - Killing assays (Steiner, et al., others) • - Uptake assays (Martinez; Jansen)
FALS Sensor Fluorescence Fluorescence detector (PMT3, PMT4 etc.)
Flow Opsonophagocytic Assays Phagocytic cells Complement Ctl Positive Rx OPA Graph
Bacteria or Microspheres S. pneumoniae Microspheres
Multiplexed Flow OPA Single-plex Multiplex
Correlations between reference OPA and flow OPA 1Different strains used
Technical Considerations • Targets • 1. Bacteria • -Variable label
Variability of Labeled Bacteria Positive Cells Negative Cells
Technical Considerations • Targets • 1. Bacteria • -Variable label • 2. Beads • -Standardized label
Beads Provided a Standard Fluorescent Target CDC, Sero 4-Y Beads FA, Sero 4-Y Beads
Technical Considerations • Effector Cells • 1. Donor PMNs • 2. HL60 PMNs
Comparison of PMN and HL60 PMN Derived OPA Titers
Technical Considerations Cont. • Effector Cells • 1. Donor PMNs • 2. HL60 PMNs • a. Culture maintenance
Effects of Different Culture Conditions 38% S and G2/M 16% S and G2/M 3% S and G2/M Published Induction Protocol Modified Induction Protocol HL60 Stock 3% 18% 57%
Technical Considerations • Effector Cells • 1. Donor PMNs • 2. HL60 PMNs • a. Culture maintenance • b. Induction protocol
Effects of Culture Conditions on HL60 Differentiation and Function Normal Culture Method Roller Culture Method
Data Collection • Gating • Minimize overlap of “dead” cells within gate • Ensure gate contains a cells with ingested targets
Data Collection • Gating • Minimize overlap of “dead” cells within gate • Ensure gate contains a cells with ingested targets • Compensation • Critical in multiplexed assays
Data Analysis-Automation • Flow cytometric OPA can be automated • Sample handler • Batch file analysis of raw data files • Attractors • FlowJo • Curve fitting software to determine titer • Statlia • GLP compatible
Assay Comparisons *Overnight incubation required
Flow Cytometric OPA Technology • Can be applied to other bacteria cleared through an OP mechanism • S. aureus (Vernachio) Figure 1. Opsonization of ClfA-coated fluorescent beads. PMNs were incubated with unopsonized beads , complement opsonized beads, T1-2 plus complement opsonized beads, and non-specific human IgG1 complement opsonized beads. The phagocytic product (PP) represents the mean beads per cell multiplied by the percent fluorescent PMNs, as determined via flow cytometric analysis.
Summary • Non-infectious targets • Correlate well with reference OP method • High throughput • Automation can further increase relative throughputs • Meet GLP guidelines